Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 748

Sort by

Sort Order Select

Journal Articles

Inaccuracies of venous thromboembolism risk assessment and prevention practices among medically ill patients

Brandyn D. Lau, Aditya Bhave, Jennifer C. Yui, Rakhi Naik, Kathryn E. Dane, John Lindsley, Dauryne L. Shaffer, Peggy S. Kraus, Erik H. Hoyer, Elliott R. Haut, Michael B. Streiff

Blood Adv (2025) 9 (15): 3929–3936.

https://doi.org/10.1182/bloodadvances.2024015306

Published: 2025

Includes: Supplemental data

Journal Articles

Recurrent thrombosis and major bleeding in children treated for VTE

Stephanie F. Lenahan, Anne Blackmore, Matthew Fenchel, Evan Thomas, Joseph S. Palumbo, Cristina Tarango

Blood Adv (2025) 9 (15): 3824–3831.

https://doi.org/10.1182/bloodadvances.2025016135

Published: 2025

Journal Articles

The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component

Kari A. O. Tikkinen, Deborah M. Siegal, P. J. Devereaux, Sara V. Tornberg, Flavia K. Borges, Sandra Ofori, Jehonathan Pinthus, Bobby Shayegan, Lauri I. Lavikainen, Gordon H. Guyatt, Pavel S. Roshanov

Blood Adv (2025) 9 (15): 3837–3844.

https://doi.org/10.1182/bloodadvances.2024015515

Published: 2025

Journal Articles

The balancing act after pediatric venous thromboembolism

Hilary Whitworth, Leslie Raffini

Blood Adv (2025) 9 (15): 3905–3906.

https://doi.org/10.1182/bloodadvances.2025016871

Published: 2025

Journal Articles

Exorcizing the devil of factor VIII inhibitors

Paul C. Moorehead

Blood Adv (2025) 9 (15): 3716–3717.

https://doi.org/10.1182/bloodadvances.2025016643

Published: 2025

Journal Articles

Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states

Diego Butera, Aster E. Pijning, Nathan G. Avery, Carmen H. Coxon, Clive Metcalfe, Angelina Mimoun, Sébastien Lacroix-Desmazes, Paul Clint Spiegel, Jr., Philip J. Hogg

Blood Adv (2025) 9 (15): 3706–3715.

https://doi.org/10.1182/bloodadvances.2025016474

Published: 2025

Includes: Supplemental data

Journal Articles

A global survey on practice changes and barriers to the use of direct oral anticoagulants in children

M. Laura Avila, Erica Di Ruggiero, Jennifer Vincelli, Leonardo R. Brandão

Blood Adv (2025) 9 (15): 3718–3727.

https://doi.org/10.1182/bloodadvances.2025016681

Published: 2025

Includes: Supplemental data

Journal Articles

Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX

Enhao Li, Zekun Li, Jinzeng Wang, Haoyang Wu, Yilun Xue, Can Lou, Zhenping Chen, Feng Liu, Wenman Wu, Qiulan Ding, Runhui Wu, Xuefeng Wang, Jing Dai

Blood Adv (2025) 9 (15): 3967–3978.

https://doi.org/10.1182/bloodadvances.2025015799

Published: 2025

Includes: Supplemental data

Journal Articles

A Disrupted Adenosinergic Axis Facilitates Platelet Activation in APS: Exploring a Novel Therapeutic Target

Somanathapura K NaveenKumar, Thalia G Newman, Bruna Mazetto Fonseca, Srilakshmi Yalavarthi, Mariane C Flores Nascimento, Kaitlyn Sabb, Katarina Kmetova, Emily Chong, Kavya Sugur, Caroline H Ranger, Megan P Tompkins, Cyrus Sarosh, Jacqueline A Madison, Ajay Tambralli, Jordan K Schaefer, Michael Holinstat, Yu Zuo, Jason S. Knight

Blood Adv bloodadvances.2025016162.

https://doi.org/10.1182/bloodadvances.2025016162

Published: 2025

Includes: Supplemental data

Journal Articles

Untangling profiles of postthrombotic syndrome using unsupervised machine learning

Aaron F. J. Iding, Vincent ten Cate, Hugo ten Cate, Philipp S. Wild, Arina J. ten Cate-Hoek

Blood Adv (2025) 9 (14): 3631–3641.

https://doi.org/10.1182/bloodadvances.2025015829

Published: 2025

Includes: Supplemental data

Journal Articles

Reassessing the Villalta score’s use of signs and symptoms

Steven H. Yale, Halil Tekiner, Regina Wilson, Eileen S. Yale

Blood Adv (2025) 9 (14): 3642–3643.

https://doi.org/10.1182/bloodadvances.2025016750

Published: 2025

Journal Articles

Dietary Tryptophan Augments Cancer-Associated Venous Thrombosis Mitigated by Indoleamine 2,3-Dioxygenase 1 Inhibition

Saran Lotfollahzadeh, Asha Jose, Dr, Xiaosheng Yang, Tanvi Bathla, Adam Lazowski, Isaac Hoekstra, Kashvi Sethuraman, Sowmya Potluri, Karlynn Dulberger, Jennifer La, Nathanael Fillmore, Maria Del Carmen Piqueras, Norman Lee, Howard J Cabral, Katya Ravid, Vipul Chitalia

Blood Adv bloodadvances.2025017079.

https://doi.org/10.1182/bloodadvances.2025017079

Published: 2025

Includes: Supplemental data

Journal Articles

Hybridization Capture Long-Read Sequencing & De Novo Assembly of Homologous Haplotypes: A Comprehensive Hemophilia Test

Boyan Liu, Ruixia Xu, Siqian Ma, Mengnan Gu, Lingyin Kong, Lu Zhou, Haoning Liu, Shujin Chen, Yuyan Yang, Ziqiang Yu, Bo Liang, Miao Jiang

Blood Adv bloodadvances.2025016200.

https://doi.org/10.1182/bloodadvances.2025016200

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes and survival prediction in adults with sickle cell disease treated with extracorporeal membrane oxygenation

Alison Grazioli, Michael Edward Plazak, Kate Willsey, Joseph Rabin, Raymond P Rector, Leonid Belyayev, Allison S Lankford, Thomas M Scalea, Aakash Shah, Bradley S Taylor, Mark T Gladwin

Blood Adv bloodadvances.2025016368.

https://doi.org/10.1182/bloodadvances.2025016368

Published: 2025

Includes: Supplemental data

Journal Articles

2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease

Paula D. James, Veronica H. Flood, Nathan T. Connell

Blood Adv (2025) 9 (14): 3553–3555.

https://doi.org/10.1182/bloodadvances.2025016512

Published: 2025

Journal Articles

An αIIbβ3 ligand-mimetic murine monoclonal antibody that produces platelet activation by engaging the FcγIIa receptor

Jialing Wang, Lorena Buitrago, Lu Wang, Jihong Li, Thomas Walz, Barry S. Coller

Blood Adv (2025) 9 (14): 3518–3529.

https://doi.org/10.1182/bloodadvances.2024015368

Published: 2025

Includes: Supplemental data

Journal Articles

Red blood cell aggregation within a blood clot causes platelet-independent clot shrinkage

Alina D. Peshkova, Ekaterina K. Rednikova, Rafael R. Khismatullin, Oleg V. Kim, Vladimir R. Muzykantov, Prashant K. Purohit, Rustem I. Litvinov, John W. Weisel

Blood Adv (2025) 9 (14): 3418–3428.

https://doi.org/10.1182/bloodadvances.2024015533

Published: 2025

Includes: Supplemental data

Journal Articles

Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice

Marie Octave, Laurence Pirotton, Emma de Cartier d'Yves, Alice Marino, Jérôme Ambroise, Martin Giera, Bruno Guigas, Audrey Ginion, Valentine Robaux, Marijke J.E. Kuijpers, Constance C.F.M.J. Baaten, Johan W.M. Heemskerk, Zoltan Nagy, Yotis A Senis, Davide Brusa, Caroline Bouzin, Luc Bertrand, Christophe Beauloye, Sandrine Horman

Blood Adv bloodadvances.2025015796.

https://doi.org/10.1182/bloodadvances.2025015796

Published: 2025

Includes: Supplemental data

Journal Articles

Incomplete Harms Reporting in Systematic Reviews of Direct Oral Factor Xa Inhibitors

Jack Rea, DO, Chase Lee, Micah Kee, Brayden Rucker, Holly Flores, Corbin Walters, Taryn Haney, Alicia Tomlin, Adam Khan, Matt Vassar

Blood Adv bloodadvances.2025017363.

https://doi.org/10.1182/bloodadvances.2025017363

Published: 2025

Includes: Supplemental data

Journal Articles

Dose-Reduced Apixaban for Secondary Prophylaxis in Severely Obese Patients: A Single Center Analysis

Eliot A Rapoport, Noelle W Townsend, Nadine Farhat, Parth Patel, Henny H Billett

Blood Adv bloodadvances.2025016037.

https://doi.org/10.1182/bloodadvances.2025016037

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Inaccuracies of venous thromboembolism risk assessment and prevention practices among medically ill patients

Recurrent thrombosis and major bleeding in children treated for VTE

The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component

The balancing act after pediatric venous thromboembolism

Exorcizing the devil of factor VIII inhibitors

Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states

A global survey on practice changes and barriers to the use of direct oral anticoagulants in children

Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX

A Disrupted Adenosinergic Axis Facilitates Platelet Activation in APS: Exploring a Novel Therapeutic Target

Untangling profiles of postthrombotic syndrome using unsupervised machine learning

Reassessing the Villalta score’s use of signs and symptoms

Dietary Tryptophan Augments Cancer-Associated Venous Thrombosis Mitigated by Indoleamine 2,3-Dioxygenase 1 Inhibition

Hybridization Capture Long-Read Sequencing & De Novo Assembly of Homologous Haplotypes: A Comprehensive Hemophilia Test

Outcomes and survival prediction in adults with sickle cell disease treated with extracorporeal membrane oxygenation

2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease

An αIIbβ3 ligand-mimetic murine monoclonal antibody that produces platelet activation by engaging the FcγIIa receptor

Red blood cell aggregation within a blood clot causes platelet-independent clot shrinkage

Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice

Incomplete Harms Reporting in Systematic Reviews of Direct Oral Factor Xa Inhibitors

Dose-Reduced Apixaban for Secondary Prophylaxis in Severely Obese Patients: A Single Center Analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only